Pharmaceutical litigation: e.g.: the benzodiazepine multiparty litigation for manufacturers and combined oral contraceptive multiparty litigation for manufacturers; carbon disulphide group litigation; general product liability, licensing and judicial review.
I have been instructed in a number of licensing and regulatory matters by the Medicines and Healthcare Products Regulatory Agency. There are always new and interesting challenges to face with a continuous flow of new products coming on the market place, vaccines against Covid-19 and changes in the regulation of medicines since we have left the EU. Safety being paramount, public confidence in the regulatory authorities is essential.